Asthma: An inflammatory mediator soup

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 49, 1999, Pages 55-61

  Björnsdottir, Unnur Steina ^a   Cypcar, D M ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b Regl Allerg and Asthma Consult PA   (United States)

Author keywords

Adhesion molecules; Cytokines; Eosinophils; Inflammation; T cells

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; CELL ADHESION MOLECULE; CHEMOTACTIC FACTOR; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; IMMUNOGLOBULIN PRODUCTION; MACROPHAGE; MAST CELL; MUCUS SECRETION; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE ACTIVATION;

ASTHMA; CELL ADHESION MOLECULES; CELL MOVEMENT; CYTOKINES; EOSINOPHILS; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0039101293     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Sheffer AL. Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991;88:427-438.
2. Busse WW. Mechanisms of inflammation and their therapeutic implications in the asthmatic patient. Ann Allergy 1992;69:261-266.
3. Bousquet J, Chanez P, Campbell A, et al. Inflammatory processes in asthma. Int Arch Allergy Appl Immunol 1991;94:227-232.
4. Holgate ST. Mediator and cytokine mechanisms in asthma: the Altounyan Address. Thorax 1993;48:103-110.
5. Bentley AM, Qui Meng, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils and cytokine messenger RNA for IL-5 and GM-CSF in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
6. Robinson DS, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in atopic asthmatics. J Allergy Clin Immunol 1993;92:313-324.
7. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry and function of natural adherence molecule (ICAM-1). J Immunol 1986;137:245-254.
8. Thomhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 1991;146:592-598.
9. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
10. Kowalski MS, Diddier A, Kaliner MA. Neurogenic inflammation in the airways. Am Rev Respir Dis 1989;140:101-109.
11. Bjömsdottir US, Quan SF, Busse WW. Asthma and rhinitis. In: Busse WW, Holgate ST, editors. Eosinophils and asthma. Boston, MA: Blackwell Scientific. 1995:328-347.
12. Metzger WJ, Nugent K, Richersson HB, et al. Methods for bronchoalveolar lavage in asthmatic patients following bronchoprovocation and local antigen challenge. Chest 1985;87:165-195.
13. Bousquet J, Chanez P, LaCoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
14. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized double-blind parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
15. Kroegel C, Costabel U, Matthys H, Barnes PJ. Die Pathogenetische Bedeutung des Eosinophilen Granulozyten. I. Morphologie, Biochemie und Effectormechanismen. Dtsch Med Wochenschr 1988;113:1405-1411.
16. Frigas E, Loegering DA, Solley GO, Farrow GM, Gleich GJ. Elevated levels of eosinophil major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981;56:345-353.
17. Gleich GJ, Adolphson CR. The eosinophil leukocyte: structure and function. Adv Immunol 1986;39:177-253.
18. Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986;77:527-537.
19. Brofman JD, White SR, Blake JS, Munoz NM, Gleich GJ, Leff AR. Epithelial augmentation of trachealis contraction caused by major basic protein of eosinophils. J Appl Physiol 1989;66:1867-1873.
20. de Monchy JG, Kauffman HF, Venge P. Bronchoalveolar eosinophila during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1989;131:373-376.
21. Durham SR, Logering DA, Dunnette S, Gleich GJ, Kay AB. Blood eosinophils and eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989;84:931-936.
22. Sonoda Y, Arai N, Ogawa M. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony stimulating factor (GM-CSF) and interleukin 5. Leukemia 1989;3:12-18.
23. Walker C, Virchow JC Jr, Bruijnzeel PL, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991;146:1829-1835.
24. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 1989;19:701-705.
25. Sedgwick JB, Calhoun WJ, Vritis RF, Bates ME, McAllister PK, Busse WW. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 1992;149:3710-3718.
26. Lopez AF, Vadas MA. Recombinant interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-224.
27. Moqbel R, Hamid Q, Ying S, et al. Expression of mRNA and immunoreactivity for the granulocyte/macrophage-colony stimulating factor in activated human eosinophils. J Exp Med 1991;174:749-752.
28. 4. Proc Natl Acad Sci U S A 1983;80:7626-7630.
29. Lee T, Lenihan DJ, Malone B, Roddy LL, Wasseman SI. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem 1984;259:5526-5530.
30. Bradley BL, Azzawi M, Assoufi B, et al. Eosinophils, T-lymphocytcs, mast cells, neutrophils and macrophages in bronchial biopsies from atopic asthmatics: comparison with atopic non-asthma and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-674.
31. Taylor KJ, Luksza AR. Peripheral blood eosinophil counts and bronchial hyperresponsiveness. Thorax 1987:42:452-456.
32. Motojima S, Frigas E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989:139:801-805.
33. Barnes PJ. What is the role of nerves in chronic asthma and symptoms? Respir Crit Care Med 1996;153 Suppl 2:S5-S8.
34. Barne PJ, Baraniuk J, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991;144:1187-1198, 1391-1399.
35. Solway J, Leff AR. Sensory neuropeptides and airway function. J Appl Physiol 1991;71:2077-2087.
36. Erjefält JS, Korsgren M, Nilsson MC, Sundler F, Persson CGA. Association between inflammation and epithelial damage-restitution processes in allergic airways in vivo. Clin Exp Allergy 1997;27:1344-1355.
37. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for culture fibroblasts. J Clin Invest 1991;88:493-499.
38. Westergren-Thorsson G, Sarnstrand B, Fransson LA, et al. TGF-beta enhances the production of hyaluronan in human lung but not in skin fibroblasts. Exp Cell Res 1990;186:192-195.
39. Albelda SM, Brick CA. Integrins and other cell adhesion molecules. FASEB J 1990:4:2868-2880.
40. Leff AR, Hamann KJ, Wegner CD. Inflammation and cell-cell interactions in airway hyperresponsiveness. Am J Physiol 1991;260:L189-L206.
41. Schleimer RP, Strebinsky SA, Kaiser J, et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1086-1092.
42. Del Prete G, Maggi E, Parronchi P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supematants. J Immunol 1988;140:4193-4198.
43. Wardlaw AJ, Walsh GM, Symon FA. Mechanisms of eosinophil and basophil migration. Allergy 1994;49:797-807.
44. Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 1990;68:779-786.
45. Hartnel A, Robinson DS, Kay AB, Wardlaw AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 1993;80:281-286.
46. Sedgwick JB, Calhoun WJ, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991;144:1274-1281.
47. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56:839-847.
48. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Ruthlein R. Intracellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
49. Abraham WM, Sielezak MW, Ahmed A, et al. α-4 mediated integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 1994;93:776-787.
50. Mosmann TR, Cherwinski HM, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T-cell clones. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
51. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 1987;138:3688-3694.
52. Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster interleukin-3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony stimulating factor, in allergen-induced late phase cutaneous reactions in a topic subjects. J Exp Med 1991;173:775-778.
53. Gajewski TF, Joyce J, Fitch FW. Antiproliferative effect of interferon-γ in immune regulation. III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant TFN-γ. J Immunol 1989;143:15-20.
54. Fiorentino D, Bond HW, Mosmann TR. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2135-2140.
55. Florentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-3451.
56. Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+T lymphocytes. J Immunol 1995;155:111-117.
57. Romagnani S. Atopic allergy and other hypersensitivities. Curr Opin Immunol 1995;7:745-750.
58. Gauchat JF, Lebman DA, Coffman RL, Gascan H, de Vries JE. Structure and expression of germline ε transcripts in human B cells induced by IL-4 to switch to IgE production. J Exp Med 1990;72:463-473.
59. Punnonen J, Aversa G, Cocks BG, et al. Interleukin 13 induces interleukin-4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 1993;90:3730-3734.
60. Punnonen J, Aversa G, Cocks BG, de Vries JE. Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells. Allergy 1994:49:576-586.
61. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987;236:944-947.
62. Leung DY, Martin RJ, Szefler SJ, et al. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid resistant asthma. J Exp Med 1995;181:33-40.
63. Tang MLK, Kemp AS, Thorburn J, Hill DJ. Reduced interferon gamma secretion in neonates is associated with the subsequent development of atopy. Lancet 1995;344:983-985.
64. Rothenburg ME, Petersen J, Stevens RL, et al. IL-5 dependent conversion of normodense eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxicity. J Immunol 1989;143:2311-2316.
65. Wang JM, Rambaldi A, Biondi A, Chen AG, Sanderson CJ, Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 1989;19:701-705.
66. Rothenburg M, Owen W, Silberstein D, et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3. J Clin Invest 1988;81:1986-1992.
67. Owen WT Jr, Rothenberg ME, Silberstein DS, et al. Regulation of human eosinophil viability, density and function by granulocyte macrophage colony stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987;106:129-141.
68. Kita H, Gleich GJ. Chemokines active on eosinophils. Potential roles in allergic inflammation. J Exp Med 1996;183:2421-2426.
69. Bloemen PGM, Henricks PAJ, Nijkmp FP. Cell adhesion molecules and asthma. Clin Exp Allergy 1997;27:128-141.
70. Secrist H, Cholen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-2130.
71. Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT. Regulation of disease susceptibility: decreased prevalence of IgE mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996;97:1402-1408.
72. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-79.
73. Yoshimoto T, Okamura H, Tagawa Y, Iwakura Y, Nakanash K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc Natl Acad Sci U S A 1997;94:3948-3953.
74. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation and TH2 cytokine expression in mice. J Exp Med 1995;182:1527-1536.